This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
User:Alisha, Deepa, Pamiz/Sandbox 1
From Proteopedia
(Difference between revisions)
(→Introduction) |
(→Introduction) |
||
| Line 4: | Line 4: | ||
[[Image:eso.jpg|300px|left|thumb|'''2D Structure & Biochemical Parameters of Esomeprazole''' Esomeprazole has two important pyridine and benzimidazole moieties linked through a methylenesulfinyl group. pKa, IC50, AUC, Cmax, and half life values of Esomeprazole. | [[Image:eso.jpg|300px|left|thumb|'''2D Structure & Biochemical Parameters of Esomeprazole''' Esomeprazole has two important pyridine and benzimidazole moieties linked through a methylenesulfinyl group. pKa, IC50, AUC, Cmax, and half life values of Esomeprazole. | ||
]]'''Esomeprazole''' is the (S) enantiomer of Omeprazole. Esomperazole is a '''Proton Pump Inhibitor (PPI)''' that binds to '''H+/K+-ATPase''' and inhibits the secretion of gastric acid from parietal cells into the lumen of the stomach. Esomeprazole’s commercial brand name, Nexium, is used to treat Gastro-esophageal Reflux Disease (GERD), peptic and gastric ulcers, and Zollinger-Ellison syndrome.<ref name="one">[Mayo Clinic. Esomeprazole (Oral Route). http://www.mayoclinic.com/health/drug-information/DR603283 (accessed November 11, 2013).]</ref> | ]]'''Esomeprazole''' is the (S) enantiomer of Omeprazole. Esomperazole is a '''Proton Pump Inhibitor (PPI)''' that binds to '''H+/K+-ATPase''' and inhibits the secretion of gastric acid from parietal cells into the lumen of the stomach. Esomeprazole’s commercial brand name, Nexium, is used to treat Gastro-esophageal Reflux Disease (GERD), peptic and gastric ulcers, and Zollinger-Ellison syndrome.<ref name="one">[Mayo Clinic. Esomeprazole (Oral Route). http://www.mayoclinic.com/health/drug-information/DR603283 (accessed November 11, 2013).]</ref> | ||
| - | Ulcers caused by the bacterium ''Helicobacter pylori'' can be treated using Esomeprazole in conjunction with proper antibiotics.<ref name="one"/> Gastric acid is released through the H+/K+-ATPase pump, which is the final step in acid release. | + | Ulcers caused by the bacterium ''Helicobacter pylori'' can be treated using Esomeprazole in conjunction with proper antibiotics.<ref name="one"/> Gastric acid is released through the H+/K+-ATPase pump, which is the final step in acid release. <ref name="two">[National Institutes of Health: DailyMed. NEXIUM (Esomeprazole magnesium) capsule, delayed release [A-S Medication Solutions LLC]. http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9af7a792-d38a-4b2a-b5d6-855d2183b029 (accessed November 11, 2013).]</ref> Esomeprazole is a specific, irreversible inhibitor of the pump. <ref name="two"> |
[[Image:PPI gif.gif]] | [[Image:PPI gif.gif]] | ||
Revision as of 20:06, 6 December 2013
Introduction
Ulcers caused by the bacterium Helicobacter pylori can be treated using Esomeprazole in conjunction with proper antibiotics.[1] Gastric acid is released through the H+/K+-ATPase pump, which is the final step in acid release. [2] Esomeprazole is a specific, irreversible inhibitor of the pump. [2]
